In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of
Discover how Restorin, a cutting-edge nutraceutical backed by Harvard and Mayo Clinic research, promotes better sleep, energy, focus, and healthy aging.